|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.59 USD | -0.60% |
|
+2.24% | -17.79% |
| Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
| Apr. 10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
Ionis Pharmaceuticals, Inc. provided earnings guidance for the year 2024. For the year, the company expects revenues to be >$575 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.79% | 6.07B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
IONIS PHARMACEUTICALS, INC. 
